The glutamate hypothesis in ALS: pathophysiology and drug development

Current medicinal chemistry, 2014 - ingentaconnect.com
Amyotrophic lateral sclerosis (ALS) is an age-related neurodegenerative disorder that is
believed to have complex genetic and environmental influences in the pathogenesis, but …

The glutamate hypothesis in ALS: pathophysiology and drug development

H Blasco, S Mavel, P Corcia… - Current medicinal …, 2014 - pubmed.ncbi.nlm.nih.gov
Amyotrophic lateral sclerosis (ALS) is an age-related neurodegenerative disorder that is
believed to have complex genetic and environmental influences in the pathogenesis, but …

The glutamate hypothesis in ALS: pathophysiology and drug development.

H Blasco, S Mavel, P Corcia… - Current Medicinal …, 2014 - europepmc.org
Amyotrophic lateral sclerosis (ALS) is an age-related neurodegenerative disorder that is
believed to have complex genetic and environmental influences in the pathogenesis, but …

[PDF][PDF] The Glutamate Hypothesis in ALS: Pathophysiology and Drug Development.

H Blasco, S Mavel, P Corcia… - Current Medicinal …, 2014 - scholar.archive.org
Amyotrophic lateral sclerosis (ALS) is an age-related neurodegenerative disorder that is
believed to have complex genetic and environmental influences in the pathogenesis, but …

The Glutamate Hypothesis in ALS: Pathophysiology and Drug Development.

H Blasco, S Mavel, P Corcia, PH Gordon - Current Medicinal Chemistry, 2014 - hal.science
Amyotrophic lateral sclerosis (ALS) is an age-related neurodegenerative disorder that is
believed to have complex genetic and environmental influences in the pathogenesis, but …

[PDF][PDF] The Glutamate Hypothesis in ALS: Pathophysiology and Drug Development.

H Blasco, S Mavel, P Corcia, PH Gordon - Current Medicinal Chemistry, 2014 - hal.science
Amyotrophic lateral sclerosis (ALS) is an age-related neurodegenerative disorder that is
believed to have complex genetic and environmental influences in the pathogenesis, but …